Vectored expression of the broadly neutralizing antibody FI6 in mouse airway provides partial protection against a new avian influenza a virus, H7N9

Clinical and Vaccine Immunology

Volumn 20, Issue 12, 2013, Pages 1836-1837

  Limberis, Maria P ^a   Racine, Trina ^b   Kobasa, Darwyn ^b,c   Li, Yan ^d   Gao, George F ^e   Kobinger, Gary ^b,c   Wilson, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e Center for Disease Control   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; DRUG EFFICACY; IMMUNE RESPONSE; INFECTION PREVENTION; INFECTION RATE; INFLUENZA; INFLUENZA H7N9; INFLUENZA VIRUS A; INFLUENZA VIRUS A H7N9; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS LOAD; VIRUS SURVIVAL;

ANIMALS; ANTIBODIES, NEUTRALIZING; DEPENDOVIRUS; GENETIC VECTORS; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; NASOPHARYNX; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84888603787     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00545-13     Document Type: Article

References (10)

1. World Health Organization. 2013. Human infection with avian influenza A(H7N9) virus-update. Disease outbreak news. WHO, Geneva, Switzerland. http://www.who.int/csr/don/2013-07-20/en/index.html.
2. Zhou J, Wang D, Gao R, Zhao B, Song J, Qi X, Zhang Y, Shi Y, Yang L, Zhu W, Bai T, Qin K, Lan Y, Zou S, Guo J, Dong J, Dong L, Wei H, Li X, Lu J, Liu L, Zhao X, Huang W, Wen L, Bo H, Xin L, Chen Y, Xu C, Pei Y, Yang Y, Zhang X, Wang S, Feng Z, Han J, Yang W, Gao GF, Wu G, Li D, Wang Y, Shu Y. 2013. Biological features of novel avian influenza A (H7N9) virus. Nature 499:500-503.
3. Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, Xiang N, Chen E, Tang F, Wang D, Meng L, Hong Z, Tu W, Cao Y, Li L, Ding F, Liu B, Wang M, Xie R, Gao R, Li X, Bai T, Zou S, He J, Hu J, Xu Y, Chai C, Wang S, Gao Y, Jin L, Zhang Y, Luo H, Yu H, Gao L, Pang X, Liu G, Shu Y, Yang W, Uyeki TM, Wang Y, Wu F, Feng Z. 24 April 2013. Preliminary report: epidemiology of the avian influenzaA(H7N9) outbreak in China. N. Engl. J. Med. [Epub ahead of print.] doi:10.1056/ NEJMoa1304617.
4. Zhang Q, Shi J, Deng G, Guo J, Zeng X, He X, Kong H, Gu C, Li X, Liu J, Wang G, Chen Y, Liu L, Liang L, Li Y, Fan J, Wang J, Li W, Guan L, Li Q, Yang H, Chen P, Jiang L, Guan Y, Xin X, Jiang Y, Tian G, Wang X, Qiao C, Li C, Bu Z, Chen H. 2013. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 341:410-414.
5. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, Silacci C, Fernandez-Rodriguez BM, Agatic G, Bianchi S, Giacchetto-Sasselli I, Calder L, Sallusto F, Collins P, Haire LF, Temperton N, Langedijk JP, Skehel JJ, Lanzavecchia A. 2011. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850-856.
6. Limberis MP, Adam VS, Wong G, Gren J, Kobasa D, Ross TM, Kobinger GP, Tretiakova A, Wilson JM. 2013. Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza. Sci. Transl. Med. 5:187ra72.
7. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y. 2013. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368:1888-1897.
8. World Health Organization. 2013. Laboratory biorisk management for laboratories handling human specimens suspected or confirmed to contain avian influenza A (H7N9) virus causing human disease: interim recommendations. WHO, Geneva, Switzerland. http://www. who.int/influenza/human-animal-interface/ influenza-h7n9/Interim RecLaboratoryBioriskManagementH7N9-10May13.pdf.
9. Centers for Disease Control and Prevention. 2013. Interim risk assessment and biosafety level recommendations for working with influenza A (H7N9) Viruses. CDC, Atlanta, GA. http://www.cdc.gov/flu/avianflu/h7n9/risk-assessment. htm.
10. Government of Canada. 2009. Human pathogens and toxins act. Government of Canada, Ottawa, Ontario, Canada. http://lois-laws.justice.gc .ca/eng/acts/H-5.67/index.html.